Wildcat Capital Management, LLC
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 18, 2025), Wildcat Capital Management, LLC reported 6 stock positions worth $168.3 million. Its top holding was Frontier (ULCC) at 60.5% of the portfolio, followed by RLX Technology Inc.-ADR (RLX, 23.7%) and Tic Solutions (TIC, 9.8%). Compared with Q1 2025, it sold out of 2. The biggest sale was an exit from Centessa Pharmaceuticals (CNTA).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001582384
- Portfolio Value
- $168.3M (Q2 2025)
- SEC Filing
- 0001999371-25-009410 ↗ filed Jul 18, 2025
Holdings Value
Holdings 6 stocks · $168.3M
| ULCC Frontier Group Holdings Inc. | 60.52% | 28,061,351 | $101.9M | No change |
| RLX RLX Technology Inc.-ADR | 23.70% | 18,046,195 | $39.9M | No change |
| TIC Tic Solutions Inc. filed as ACUREN CORP | 9.84% | 1,500,000 | $16.6M | No change |
| URGN Urogen Pharma Ltd. | 4.03% | 495,606 | $6.8M | No change |
| ALLO Allogene Therapeutics Inc. | 1.85% | 2,920,787 | $3.1M | No change |
| SLXN Silexion Therapeutics Corp. | 0.05% | 113,428 | $92K | No change |
Portfolio Sells Q1 2025 → Q2 2025
Portfolio Buys Q1 2025 → Q2 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $228.5M | ULCC, ALLO, CHYM |
| Q1 2026 | 2 | $106.2M | ULCC, ALLO |
| Q4 2025 | 3 | $136.5M | ULCC, ALLO, PCOR |
| Q3 2025 | 5 | $145.1M | ULCC, RLX, ALLO, TTAN, GTLB |
| Q2 2025 | 6 | $168.3M | ULCC, RLX, TIC, URGN, ALLO |
| Q1 2025 | 8 | $187.4M | ULCC, RLX, TIC, URGN, ALLO |
| Q4 2024 | 8 | $252.7M | ULCC, RLX, ALLO, URGN, KRON |
| Q3 2024 | 7 | $204.6M | ULCC, RLX, ALLO, URGN, SKILLZ INC |
| Q2 2024 | 16 | $408.6M | ULCC, FYBR, MCO, MSFT, RLX |
| Q1 2024 | 16 | $275.5M | FYBR, GSHD, MCO, MSFT, RLX |